The most active researchers, institutions, and subtopics in Acute Myeloid Leukemia, from recent PubMed records. Public authorship only, every figure verifiable by PMID.
Analyzed 599 recent PubMed papers (2021-2026) matching "acute myeloid leukemia targeted treatment". Source: NLM PubMed. Generated July 2026.
| # | Researcher | Affiliation | Papers |
|---|---|---|---|
| 1 | Loghavi Sanam | The University of Texas MD Anderson Cancer Center | 7 |
| 2 | Ravandi Farhad | The University of Texas MD Anderson Cancer Center | 6 |
| 3 | Marcucci Guido | Gehr Family Center for Leukemia Research | 6 |
| 4 | Zhang Bin | Gehr Family Center for Leukemia Research | 6 |
| 5 | Huang He | the First Affiliated Hospital | 5 |
| 6 | Zhang Lianjun | Beckman Research Institute | 5 |
| 7 | Yang Yang | Children's Hospital of Soochow University | 5 |
| 8 | Wang Li | The First Affiliated Hospital of Chongqing Medical Univers | 5 |
| 9 | Zhang Lei | Beckman Research Institute | 4 |
| 10 | Kuo Ya-Huei | Gehr Family Center for Leukemia Research | 4 |
| 11 | Wang Yan | Affiliated Hospital of Shandong University of Traditional | 4 |
| 12 | Li Yizhen | Children's Hospital of Soochow University | 4 |
| 13 | Mina Alain | Yale School of Medicine | 4 |
| 14 | Fu Yu-Hsuan | Gehr Family Center for Leukemia Research | 4 |
| 15 | Zhang Ying | West China Hospital | 4 |
| 16 | Wang Yu | Tongji Hospital | 4 |
| 17 | Takahashi Shinichiro | Tohoku Medical and Pharmaceutical University | 4 |
| 18 | Wang Jianxiang | National Clinical Research Center for Blood Diseases | 4 |
Ranked by recent publication volume; names not yet disambiguated and not citation-weighted. The full brief adds ORCID disambiguation, citation weighting, and clinical-trial investigator data.
TP53 Amplification, a Rare but Recurrent Alteration in Myeloid Neoplasms. (2026) · PMID 42478550
Extracellular Vesicles in Acute Myeloid Leukemia: Opportunities and Obstacles for Therapeutic Advancement. (2026) · PMID 42478125
G3BP2 confers venetoclax resistance by stabilizing ELF1-mediated MCL1 transcription in acute myeloid leukemia. (2026) · PMID 42477086
SLC25A51 and mitochondrial NAD⁺ transport in acute myeloid leukemia: mechanisms, therapeutic potential, and translational perspect (2026) · PMID 42472419
Newly diagnosed acute myeloid leukemia in Fit patients: 2026 treatment algorithms. (2026) · PMID 42471330
A full Acute Myeloid Leukemia brief adds citation weighting, name disambiguation, clinical-trial investigators, and a cited PDF, scoped to your exact molecule, competitor set, or region.